Abbott's Fourth-Quarter Results Meet Our Expectations; Fair Value Estimate Remains Unchanged
Abbott Laboratories reported fourth-quarter and full-year results that were very consistent with our projections, and we’re leaving our $44 fair value estimate unchanged. The addition of wide-moat St. Jude Medical has not tipped Abbott over the edge into wide-moat territory, and we remain comfortable with Abbott’s narrow economic moat rating. If we see significant progress in the firm’s ability to invest in the development of more revolutionary technologies and pioneer new markets, we would rev...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.